Mitochondrial dysfunction in a patient with crohn disease: Possible role in pathogenesis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 38, Issue 5, 2004, Pages 534-538

  Restivo, Natalie L ^a   Srivastava, Maya D ^a   Schafer, Irwin A ^a   Hoppel, Charles L ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; CHILD; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; HUMAN; METABOLISM; MITOCHONDRION; OXIDATIVE PHOSPHORYLATION;

CHILD; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; OXIDATIVE PHOSPHORYLATION;

EID: 3543144240     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/00005176-200405000-00014     Document Type: Article

References (21)

1. Gudz TI, Tserng K-Y, Hoppel CL. Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide. J Biol Chem 1997;272(39):24154-8.
2. Schulze-Osthoff K, Bakker, AC, Vanhaesebroeck B, et al. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 1992;267(8): 5317-23.
3. Srivastava BI, Minowada J. Terminal transferase immunofluorescence, enzyme markers and immunologic profile of human leukemia-lymphoma cell lines representing different levels of differentiation. Leuk Res 1983;7(3):331-8.
4. Hoppel CL, Kerr DS, Dahms B, et al. Deficiency of the reduced nicotinamide adenine dinucleotide dehydrogenase component of complex I of mitochondrial electron transport: fatal infantile lactic acidosis and hypermetabolism with skeletal-cardiac myopathy and encephalopathy. J Clin Invest 1987;80:71-7.
5. Hoppel CL, DiMarco J, Tandler B. Riboflavin and rat hepatic cell structure and function. Mitochondrial oxidative metabolism in deficiency states. J Biol Chem 1979;254:4164-70.
6. Krahenbuhl S, Chang M, Brass EP, et al. Decreased activities of ubiquinol: ferricytochrome C oxidoreductase (Complex III) and ferrocytochrome C; oxygen oxidoreductase (Complex IV) in liver mitochondria from rats with hydroxycobalamin [c-lactam]-induced methylmalonic aciduria. J Biol Chem 1991;266:20998-1003.
7. Krahenbuhl S, Talso C, Wiesmann U, et al. Development and evaluation of a spectrophotometric assay for Complex III in isolated mitochondria, tissues and fibroblasts from rats and humans. Clin Chim Acta 1994;230:177-87.
8. Roe CR, Coates PM. Mitochondrial fatty acid oxidation disorders. In: Schriver CR, et al., eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, Inc; 1995:1501-25.
9. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases. In: Schriver CR, et al., eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, Inc; 1995:1535-83.
10. Heales SJR, Bolanos JP, Stewart VC, et al. Nitric oxide, mitochondria, and neurological disease. Biochim Biophys Acta 1999;1410: 215-28.
11. Lambert JR, Luk SC, Pritzker KP. Brown bowel syndrome in Crohn’s disease. Arch Pathol Lab Med 1980;104(4):201-5.
12. O’Morain C, Smethurst P, Levi J, et al. Subcellular fractionation of rectal biopsy homogenates from patients with inflammatory bowel disease. Scand J Gastroenterol 1985;20(2):209-14.
13. Sanchez-Alcazar JA, Hernandez I, De la Torre MP, et al. Down-regulation of tumor necrosis factor receptors by blockade of mitochondrial respiration. J Biol Chem 1995;270(41): 23944-50.
14. Suematsu N, Tsutsui H, Wen J, et al. Oxidative stress mediates tumor necrosis factor alpha induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 2003; 107(10):1418-23.
15. Minderhoud IM, Oldenberg B, van Dam PS, et al. High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency. Am J Gastroenterol 2003: 98(5):1088-93.
16. Lichtenstein GR, Bala M, Han C, et al. Infliximab improves quality of life in patients with Crohn’s disease. Inflamm Bowel Dis 2002;8(4):237-43.
17. Cauza E, Cauza K, Hanusch-Enserer U, et al. Intravenous anti-TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis. Wien Klin Wochenschr 2002;114(23-34):1004-7.
18. Hugot JP, Zouali H, Lesage S. Lessons to be learned from the NOD2 gene in Crohn’s disease. Eur J Gastroenterol Hepatol 2003;15(6):593-7.
19. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD 15 mutations in Blau syndrome. Nat Genet 2001;29(1):19-20.
20. Kurokawa T, Kikuchi T, Ohta K, et al. Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology 2003;110(10):2040-4.
21. Cogswell PC, Kashatus DF, Kiefer JA, et al. NF-kappa B and I kappa B alpha are found in the mitochondria. Evidence for regulation of mitochondrial gene expression by NF-kappa B. J Biol Chem 2003;278(5):2963-8.